Neuralgia Clinical Trials

Find Neuralgia Clinical Trials Near You

Evaluation of the Effect of Transforaminal Epidural Steroid Injection on Neuropathic Pain Using the Neuropathic Pain Scale in Patients With Lumbosacral Radiculopathy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Patients with lumbosacral radiculopathy frequently experience neuropathic pain due to nerve root compression. Transforaminal epidural steroid injection (TFESI) is commonly used for pain relief in these patients. This study aims to evaluate the effect of TFESI on neuropathic pain severity using the Neuropathic Pain Scale (NPS) in patients with lumbosacral radiculopathy. Clinical outcomes before and after the procedure will be compared.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Adults aged 18 years and older

• Patients diagnosed with lumbosacral radiculopathy based on clinical evaluation and lumbar MRI findings

• Presence of neuropathic pain symptoms associated with lumbosacral radiculopathy

• Patients scheduled to undergo transforaminal epidural steroid injection (TFESI)

• Patients able to understand and complete the study questionnaires and scales

• Voluntary written informed consent provided

Locations
Other Locations
Turkey
Marmara University Pendik Training and Research Hospital, Department of Physical Medicine and Rehabilitation
RECRUITING
Istanbul
Contact Information
Primary
Ece Reşit, MD
resitece98@gmail.com
+90 531 555 49 01
Time Frame
Start Date: 2026-08-11
Estimated Completion Date: 2027-02-20
Participants
Target number of participants: 40
Treatments
Experimental: TFESI Group
Participants with lumbosacral radiculopathy will receive transforaminal epidural steroid injection (TFESI) treatment. Neuropathic pain severity will be evaluated before and after the intervention using the Neuropathic Pain Scale (NPS).
Related Therapeutic Areas
Sponsors
Leads: Marmara University

This content was sourced from clinicaltrials.gov